Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and beta2-microglobulin in B-cell chronic lymphocytic leukemia.

Molica, S; Levato, D; Cascavilla, N; Levato, L; Musto, P

Molica, S; Levato, D; Cascavilla, N; Levato, L; Musto, P.

Affiliation

Molica S; Divisione di Ematologia, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy.

Eur J Haematol ; 62(2): 117-22, 1999 Feb.

Article in En | MEDLINE | ID: mdl-10052715

Subject(s)

Biomarkers, Tumor; Leukemia, Lymphocytic, Chronic, B-Cell/blood; Leukemia, Lymphocytic, Chronic, B-Cell/pathology; Receptors, IgE/blood; beta 2-Microglobulin/metabolism; Aged; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell/mortality; Male; Middle Aged; Multivariate Analysis; Prognosis; Prospective Studies; Survival Analysis

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Biomarkers, Tumor / Beta 2-Microglobulin / Receptors, IgE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 1999 Document type: Article Affiliation country: Italy

Search on Google

Add to My VHL

XML

PubMed Links